Übersetzung und Analyse von Wörtern durch künstliche Intelligenz ChatGPT
Auf dieser Seite erhalten Sie eine detaillierte Analyse eines Wortes oder einer Phrase mithilfe der besten heute verfügbaren Technologie der künstlichen Intelligenz:
- wie das Wort verwendet wird
- Häufigkeit der Nutzung
- es wird häufiger in mündlicher oder schriftlicher Rede verwendet
- Wortübersetzungsoptionen
- Anwendungsbeispiele (mehrere Phrasen mit Übersetzung)
- Etymologie
Orphan Drug Act, the - Übersetzung nach Englisch
Ex: There was a new pharmaceutical policy enacted in 1983 known as the Orphan Drug Act designed to increase the availability of so-called "orphan drugs" used to treat rare diseases.
Ex: There was a new pharmaceutical policy enacted in 1983 known as the Orphan Drug Act designed to increase the availability of so-called "orphan drugs" used to treat rare diseases.
Def: En una lista de encabezamientos, aquellos que no presentan ninguna relación (referencia ) con ningún otro encabezamiento de la lista.
Ex: Accessibility is related to the density of the cross-reference network, while the connectedness ratio is a measure of the number of orphans, a term coined to denote terms which have no linkages.
----
* orphan drug = fármaco subvencionado, medicamento subvencionado
* Orphan Drug Act, the = Ley de los Medicamentos Raros, la
* orphan home = orfanato, orfelinato
Wikipedia
An orphan drug is a pharmaceutical agent that is developed to treat certain rare medical conditions. An orphan drug would not be profitable to produce without government assistance, due to the small population of patients affected by the conditions. The conditions that orphan drugs are used to treat are referred to as orphan diseases. The assignment of orphan status to a disease and to drugs developed to treat it is a matter of public policy that depends on the legislation (if there is any) of the country.
Designation of a drug as an orphan drug has yielded medical breakthroughs that might not otherwise have been achieved, due to the economics of drug research and development. Examples of this can be that in the U.S. and the EU, it is easier to gain marketing approval for an orphan drug. There may be other financial incentives, such as an extended period of exclusivity, during which the producer has sole rights to market the drug. All are intended to encourage development of drugs which would otherwise lack sufficient profit motive to attract corporate research budgets and personnel.
